Europe

JPM: With Vascepa's U.S. expansion rolling, Amarin CEO holds off partner offers in EU
JPM: With Vascepa's U.S. expansion rolling, Amarin CEO holds off partner offers in EU
Fierce Pharma
Amarin
Vascepa
Epanova
AstraZeneca
Acasti
Europe
Flag link:
ViiV files first-in-class HIV drug in Europe
ViiV files first-in-class HIV drug in Europe
Pharmaforum
ViiV Healthcare
Europe
HIV
fostemsavir
Flag link:
AbbVie nears Allergan lockup with EU antitrust approval—and only one selloff required
AbbVie nears Allergan lockup with EU antitrust approval—and only one selloff required
Fierce Pharma
AbbVie
Allergan
antitrust
M&A
brazikumab
Europe
Flag link:
Novartis top of pile in European pharma in 2020, say Jefferies analysts
Novartis top of pile in European pharma in 2020, say Jefferies analysts
Pharmaforum
Novartis
Europe
GSK
Sanofi
AstraZeneca
Roche
Flag link:
AstraZeneca closes deal with Cheplapharm for rights to Seroquel and Seroquel XR in Europe and Russia
AstraZeneca closes deal with Cheplapharm for rights to Seroquel and Seroquel XR in Europe and Russia
Pharmaceutical Business Review
AstraZeneca
Seroquel
Seroquel XR
Russia
Europe
Cheplapharm
Flag link:
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
Xconomy
osteoporosis
Amgen
Europe
romosozumab
Evenity
Flag link:
US biosimilar launches about to turn a corner
US biosimilar launches about to turn a corner
Endpoints
biosimilars
Europe
Flag link:
Here's Why BioMarin Pharmaceutical Leapt 10.2% in November
Here's Why BioMarin Pharmaceutical Leapt 10.2% in November
Motley Fool
Biomarin
R&D
gene therapy
Europe
Flag link:
Cellectis gene editing patent upheld in Europe
Cellectis gene editing patent upheld in Europe
Seeking Alpha
gene editing
Europe
Cellectis
patents
Flag link:
Pfizer's Xeljanz gets EMA blood clots warning following FDA's similar move
Pfizer's Xeljanz gets EMA blood clots warning following FDA's similar move
Fierce Pharma
Europe
EMA
ulcerative colitis
Pfizer
Xeljanz
Flag link:
Five drugs, including two Novartis therapies, win EMA endorsement
Five drugs, including two Novartis therapies, win EMA endorsement
Endpoints
EMA
Europe
Novartis
Mayzent
Isturisa
Roche
Polivy
Jazz Pharma
Sunosi
Rigel Pharma
Tavlesse
Flag link:
The Ebola Vaccine Is Now Officially Here With Approval In Europe
The Ebola Vaccine Is Now Officially Here With Approval In Europe
Forbes
Europe
ebola virus
vaccines
Merck
Ervebo
Flag link:
Biogen signs marketing deal for two ophthalmology biosimilars
Biogen signs marketing deal for two ophthalmology biosimilars
Pharmaforum
Biogen
ophthalmology
biosimilars
Europe
Japan
Samsung Bioepis
SB11
SB15
Lucentis
Eylea
Flag link:
Secret US-UK talks on drug pricing revealed
Secret US-UK talks on drug pricing revealed
Pharmaforum
UK
Europe
trade
drug pricing
Flag link:
AstraZeneca to sell anti-psychotic medicine rights in Europe and Russia for $239m
AstraZeneca to sell anti-psychotic medicine rights in Europe and Russia for $239m
Pharmaceutical Business Review
AstraZeneca
Seroquel
antipsychotic
Europe
Russia
Cheplapharm
Flag link:
Ranking the Top 10 Biotech Clusters in Europe
Ranking the Top 10 Biotech Clusters in Europe
BioSpace
Europe
biotech
McKinsey
UK
Germany
France
Spain
The Netherlands
Flag link:
Bluebird gets European green light for gene therapy production
Bluebird gets European green light for gene therapy production
Biopharma Dive
Bluebird Bio
gene therapy
Europe
Zynteglo
Flag link:
CHMP backs world’s first Ebola vaccine from Merck, NewLink
CHMP backs world’s first Ebola vaccine from Merck, NewLink
Pharmaforum
Merck
ebola virus
vaccines
CHMP
EMA
Europe
NewLink Genetics
Flag link:
AbbVie's blockbuster hopeful Rinvoq, J&J's Spravato eye EU rollouts, thanks to new backing
AbbVie's blockbuster hopeful Rinvoq, J&J's Spravato eye EU rollouts, thanks to new backing
Fierce Pharma
AbbVie
Rinvoq
Europe
JNJ
Spravato
Flag link:
Eli Lilly to voluntarily delist from Euronext Paris exchange
Eli Lilly to voluntarily delist from Euronext Paris exchange
Marketwatch
Eli Lilly
Europe
Flag link:

Pages